ER-phagy and human diseases

Hübner, Christian A.; Đikić, Ivan

doi:10.1038/s41418-019-0444-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

ER-phagy and human diseases

MPS-Authors

/persons/resource/persons226739

Đikić, Ivan
Max Planck Fellow Group ER remodelling Group, Prof. Ivan Đikić, Max Planck Institute of Biophysics, Max Planck Society;
Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany;
Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt, Germany;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hübner, C. A., & Đikić, I. (2020). ER-phagy and human diseases. Cell Death and Differentiation, 27(3), 833-842. doi:10.1038/s41418-019-0444-0.

Cite as: https://hdl.handle.net/21.11116/0000-0005-0D0E-F

Abstract

Autophagy regulates the degradation of unnecessary or dysfunctional cellular components. This catabolic process requires the formation of a double-membrane vesicle, the autophagosome, that engulfs the cytosolic material and delivers it to the lysosome. Substrate specificity is achieved by autophagy receptors, which are characterized by the presence of at least one LC3-interaction region (LIR) or GABARAP-interaction motif (GIM). Only recently, several receptors that mediate the specific degradation of endoplasmic reticulum (ER) components via autophagy have been identified (the process known as ER-phagy or reticulophagy). Here, we give an update on the current knowledge about the role of ER-phagy receptors in health and disease.